Deutsche Bank’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.39M | Sell |
373,247
-12,230
| -3% | -$45.6K | ﹤0.01% | 1899 |
|
|
2025
Q1 | $1.06M | Sell |
385,477
-12,902
| -3% | -$35.6K | ﹤0.01% | 2097 |
|
|
2024
Q4 | $2.21M | Sell |
398,379
-144,467
| -27% | -$800K | ﹤0.01% | 1769 |
|
|
2024
Q3 | $4.53M | Buy |
542,846
+445,668
| +459% | +$3.72M | ﹤0.01% | 1296 |
|
|
2024
Q2 | $662K | Buy |
97,178
+73,526
| +311% | +$501K | ﹤0.01% | 2173 |
|
|
2024
Q1 | $155K | Buy |
23,652
+664
| +3% | +$4.36K | ﹤0.01% | 2925 |
|
|
2023
Q4 | $149K | Buy |
22,988
+539
| +2% | +$3.5K | ﹤0.01% | 2979 |
|
|
2023
Q3 | $113K | Buy |
22,449
+4,121
| +22% | +$20.7K | ﹤0.01% | 3082 |
|
|
2023
Q2 | $160K | Buy |
+18,328
| New | +$160K | ﹤0.01% | 3015 |
|
|
2022
Q2 | – | Sell |
-8,033
| Closed | -$24K | – | 4123 |
|
|
2022
Q1 | $24K | Sell |
8,033
-878
| -10% | -$2.62K | ﹤0.01% | 3899 |
|
|
2021
Q4 | $63K | Buy |
8,911
+440
| +5% | +$3.11K | ﹤0.01% | 3784 |
|
|
2021
Q3 | $88K | Buy |
8,471
+2,577
| +44% | +$26.8K | ﹤0.01% | 3865 |
|
|
2021
Q2 | $72K | Buy |
5,894
+408
| +7% | +$4.98K | ﹤0.01% | 4113 |
|
|
2021
Q1 | $121K | Buy |
+5,486
| New | +$121K | ﹤0.01% | 3827 |
|